Skip to content

Research at St Andrews

Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study

Research output: Contribution to journalArticlepeer-review

Author(s)

Stefano Aliberti, Luis F Reyes, Paola Faverio, Giovanni Sotgiu, Simone Dore, Alejandro H Rodriguez, Nilam J Soni, Marcos I Restrepo, GLIMP investigators, Devesh Janardan Dhasmana

School/Research organisations

Abstract

BACKGROUND: Antibiotic resistance is a major global health problem and pathogens such as meticillin-resistant Staphylococcus aureus (MRSA) have become of particular concern in the management of lower respiratory tract infections. However, few data are available on the worldwide prevalence and risk factors for MRSA pneumonia. We aimed to determine the point prevalence of MRSA pneumonia and identify specific MRSA risk factors in community-dwelling patients hospitalised with pneumonia.

METHODS: We did an international, multicentre study of community-dwelling, adult patients admitted to hospital with pneumonia who had microbiological tests taken within 24 h of presentation. We recruited investigators from 222 hospitals in 54 countries to gather point-prevalence data for all patients admitted with these characteristics during 4 days randomly selected during the months of March, April, May, and June in 2015. We assessed prevalence of MRSA pneumonia and associated risk factors through logistic regression analysis.

FINDINGS: 3702 patients hospitalised with pneumonia were enrolled, with 3193 patients receiving microbiological tests within 24 h of admission, forming the patient population. 1173 (37%) had at least one pathogen isolated (culture-positive population). The overall prevalence of confirmed MRSA pneumonia was 3·0% (n=95), with differing prevalence between continents and countries. Three risk factors were independently associated with MRSA pneumonia: previous MRSA infection or colonisation (odds ratio 6·21, 95% CI 3·25-11·85), recurrent skin infections (2·87, 1·10-7·45), and severe pneumonia disease (2·39, 1·55-3·68).

INTERPRETATION: This multicountry study shows low prevalence of MRSA pneumonia and specific MRSA risk factors among community-dwelling patients hospitalised with pneumonia.

FUNDING: None.

Close

Details

Original languageEnglish
Pages (from-to)1364-1376
Number of pages13
JournalLancet Infectious Diseases
Volume16
Issue number12
Early online date1 Sep 2016
DOIs
Publication statusPublished - Dec 2016

    Research areas

  • Aged, Cohort Studies, Community-Acquired Infections, Cross Infection, Female, Global Health, Hospitals, Humans, Male, Methicillin Resistance, Methicillin-Resistant Staphylococcus aureus, Pneumonia, Prevalence, Retrospective Studies, Risk Factors, Staphylococcal Infections

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia

    GLIMP investigators, Villafuerte, D., Aliberti, S., Soni, N. J., Faverio, P., Marcos, P. J., Wunderink, R. G., Rodriguez, A., Sibila, O., Sanz, F., Martin-Loeches, I., Menzella, F., Reyes, L. F., Jankovic, M., Spielmanns, M. & Restrepo, M. I., May 2020, In: Respirology. 25, 5, p. 543-551 9 p.

    Research output: Contribution to journalArticlepeer-review

  2. Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients

    GLIMP investigators, 24 Apr 2019, In: Clinical Infectious Diseases. 68, 9, p. 1482-1493 12 p.

    Research output: Contribution to journalArticlepeer-review

  3. An international perspective on hospitalized patients with viral community-acquired pneumonia

    Radovanovic, D., Sotgiu, G., Jankovic, M., Mahesh, P. A., Marcos, P. J., Abdalla, M. I., Di Pasquale, M. F., Gramegna, A., Terraneo, S., Blasi, F., Santus, P., Aliberti, S., Reyes, L. F., Restrepo, M. I. & GLIMP Study Group, Feb 2019, In: European Journal of Internal Medicine. 60, p. 54-70 17 p.

    Research output: Contribution to journalArticlepeer-review

  4. Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients

    Restrepo, M. I., Babu, B. L., Reyes, L. F., Chalmers, J. D., Soni, N. J., Sibila, O., Faverio, P., Cilloniz, C., Rodriguez-Cintron, W., Aliberti, S. & GLIMP, 9 Aug 2018, In: European Respiratory Journal. 52, 2, 1701190.

    Research output: Contribution to journalArticlepeer-review

  5. Genomic investigation unmasks evidence of transmission across mycobacterium abscessus cystic fibrosis patients

    Alateah, S., Peters, C., Dhasmana, DJ., Pettigrew, K., Fallon, R., Seagar, A., Sloan, DJ., Laurenson, IF., Holden, M. & Gillespie, S., 15 Dec 2017, In: Thorax. 72, Suppl 3, p. A56-A56

    Research output: Contribution to journalAbstractpeer-review

Related by journal

  1. Global outbreak research: harmony not hegemony

    ISARIC clinical characterisation group & Cevik, M., 2 Jul 2020, In: Lancet Infectious Diseases. 20, 7, p. 770-772 3 p.

    Research output: Contribution to journalComment/debatepeer-review

  2. Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2

    Meyerowitz, E. A., Richterman, A., Bogoch, I. I., Low, N. & Cevik, M., 7 Dec 2020, In: The Lancet Infectious Diseases.

    Research output: Contribution to journalComment/debatepeer-review

  3. Utility of broad-spectrum antibiotics for diagnosing pulmonary tuberculosis in adults: a systematic review and meta-analysis

    Divala, T. H., Fielding, K. L., Kandulu, C., Nliwasa, M., Sloan, D. J., Gupta-Wright, A. & Corbett, E. L., 1 Sep 2020, In: Lancet Infectious Diseases. 20, 9, p. 1089-1098 10 p.

    Research output: Contribution to journalArticlepeer-review

  4. High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

    Boeree, M. J., Heinrich, N., Aarnoutse, R., Diacon, A. H., Dawson, R., Rehal, S., Kibiki, G. S., Churchyard, G., Sanne, I., Ntinginya, N. E., Minja, L. T., Hunt, R. D., Charalambous, S., Hanekom, M., Semvua, H. H., Mpagama, S. G., Manyama, C., Mtafya, B., Reither, K., Wallis, R. S. & 10 others, Venter, A., Narunsky, K., Mekota, A., Henne, S., Colbers, A., Plemper van Balen, G., Gillespie, S. H., Phillips, P. P. J., Hoelscher, M. & PanACEA Consortium, Jan 2017, In: Lancet Infectious Diseases. 17, 1, p. 39-49 11 p.

    Research output: Contribution to journalArticlepeer-review

ID: 252558196

Top